Welcome to LookChem.com Sign In|Join Free
  • or
N-(1-bromoisoquinolin-3-yl)acetamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

91062-66-7

Post Buying Request

91062-66-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

91062-66-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 91062-66-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,0,6 and 2 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 91062-66:
(7*9)+(6*1)+(5*0)+(4*6)+(3*2)+(2*6)+(1*6)=117
117 % 10 = 7
So 91062-66-7 is a valid CAS Registry Number.

91062-66-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(1-bromoisoquinolin-3-yl)acetamide

1.2 Other means of identification

Product number -
Other names 3-Acetamino-1-brom-isochinolin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:91062-66-7 SDS

91062-66-7Downstream Products

91062-66-7Relevant academic research and scientific papers

Tetrahydropyridopyrimidine compound with anti-tumor activity

-

Paragraph 0581-0585, (2020/12/30)

The invention provides a tetrahydropyridopyrimidine compound shown as a formula (I) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the tetrahydropyridopyrimidine compound and the pharmaceutically acceptable salt thereof, and application of the tetrahydropyridopyrimidine compound or the pharmaceutically acceptable salt thereof in the preparation of a drug forpreventing and/or treating KRAS G12C mutant tumors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 91062-66-7